Second edition

21.qxd 3/10/08 9:58 AM Page 680
680 Substance use disorders
King MD, Day RE, Oliver JS et al. Solvent encephalopathy. BMJ
1981; 283:663–5.
King PJ, Morris JG, Pollard JD. Glue sniffing neuropathy. Aust N Z J
Med 1985; 15:293–9.
Kleber HD, Gawin FH. The spectrum of cocaine abuse and its
treatment. J Clin Psychiatry 1984; 45(suppl. 2):18–23.
Klonoff DC, Andrews BT, Obana WG. Stroke associated with
cocaine use. Arch Neurol 1989; 46:989–93.
Klonoff H, Low M, Marcus A. Neuropsychological effects of
marijuana. Can Med Assoc J 1973; 108:150–7.
Kosten TR, Price LH. Phenomenology and sequelae of 3,4methylenedioxymethamphetamine
use. J Nerv Ment Dis 1992;
180:353–4.
Kramer JC, Fischman VS, Littlefield DC. Amphetamine abuse
patterns and effects of high doses taken intravenously. JAMA
1967; 201:305–9.
Krendel DA, Ditter SM, Frankel MR. Biopsy-proven cerebral vasculitis
associated with cocaine abuse. Neurology 1990; 40:1092–4.
Kriegstein AR, Shungu DC, Millar WS et al. Leukoencephalopathy
and raised brain lactate from heroin vapor inhalation (‘chasing
the dragon’). Neurology 1999; 53:1765–73.
Kroll P. Psychoses associated with marijuana abuse in Thailand. J
Nerv Ment Dis 1975; 161:149–56.
Kuramochi H, Takahashi R. Psychopathology of LSD intoxication:
study of experimental psychosis induced by LSD-25:
description of LSD symptoms in normal oriental subjects. Arch
Gen Psychiatry 1964; 11:151–61.
Lacouture PG, Watson S, Abrams A et al. Acute isopropyl alcohol
intoxication: diagnosis and management. Am J Med 1983;
75:680–4.
Lahmeyer HW, Stock PG. Phencyclidine intoxication, physical
restraint and acute renal failure. J Clin Psychiatry 1983;
44:184–5.
Lerner AG, Gelkopf M, Skladman I et al. Clonazepam treatment of
lysergic acid diethylamide-induced hallucinogen persisting
perception disorder with anxiety features. Int Clin
Psychopharmacol 2003; 18:101–5.
Levy AB. Delirium and seizures due to abrupt alprazolam
withdrawal: case report. J Clin Psychiatry 1984; 45:38–9.
Lichtenfeld J, Rubin DB, Feldman RS. Subarachnoid hemorrhage
precipitated by cocaine snorting. Arch Neurol 1986; 41:223–4.
Liester MB, Grob CS, Bravo GL et al. Phenomenology and sequelae
of 3,4-methylenedioxymethamphetamine use. J Nerv Ment Dis
1992; 180:345–52.
Luby ED, Cohen BD, Rosenbaum G et al. Study of a new
schizophrenomimetic drug – Sernyl. Arch Neurol Psychiatry
1959; 81:363–9.
Lundh H, Tunving K. An extrapyramidal choreiform syndrome
caused by amphetamine addiction. J Neurol Neurosurg
Psychiatry 1981; 44:728–30.
Lundquist G. Delirium tremens: a comparative study of
pathogenesis, course and prognosis. Acta Psychiatr Neurol
Scand 1961; 36:443–66.
McCann UD, Szabo Z, Scheffel U et al. Positron emission
tomographic evidence of toxic effect of MDMA (‘Ecstasy’) on
brain serotonin neurons in human beings. Lancet 1998;
352:1433–7.
McCarron MM, Schulze BW, Thompson GA et al. Acute
phencyclidine intoxication: clinical patterns, complications,
and treatment. Ann Emerg Med 1981; 10:290–7.
McGuire PK, Cope H, Fahy TA. Diversity of psychopathology
associated with use of 3–4,methylenedioxyamphetamine
(‘Ecstasy’). Br J Psychiatry 1994; 165:391–5.
McLean DR, Jacobs H, Mielke BW. Methanol poisoning: a clinical
and pathological study. Ann Neurol 1980; 8:161–7.
Malcolm R, Ballenger JC, Sturgis ET et al. Double-blind controlled
trial comparing carbamazepine to oxazepam treatment of
alcohol withdrawal. Am J Psychiatry 1989; 146:617–21.
Maletzky BM. The diagnosis of pathological intoxication. Q J Stud
Alcohol 1976; 37:1215–28.
Manschreck TC, Allen DF, Neville M. Freebase psychosis: cases
from a Bahamian epidemic of cocaine abuse. Compr Psychiatry
1987; 28:555–64.
Martin WA, Jasinski DR. Physiological parameters of morphine
dependence in man – tolerance, early abstinence and
protracted abstinence. J Psychiatr Res 1969; 7:7–9.
Martinez-Cano H, Vela-Bueon A, de Iceta M et al. Benzodiazepine
withdrawal syndrome seizures. Pharmacopsychiatry 1995;
28:257–62.
Mathers DC, Ghodse AH. Cannabis and psychotic illness. Br J
Psychiatry 1992; 161:648–53.
May PRA, Ebaugh FG. Pathological intoxication, alcoholic
hallucinosis, and other reactions to alcohol: a clinical study. Q
J Stud Alcohol 1953; 14:200–27.
Melges FT. Tracking difficulties and paranoid ideation during
hashish and alcohol intoxication. Am J Psychiatry 1976;
133:1024–8.
Melges FT, Tinklenberg JR, Hollister LE et al. Temporal
disintegration and depersonalization during marijuana
intoxication. Arch Gen Psychiatry 1970; 23:204–10.
Mendelson JH, Mello NK, Lex BW et al. Marijuana withdrawal
syndrome in a woman. Am J Psychiatry 1984; 141:1289–90.
Meyer JS, Greifenstein F, Devault M. A new drug causing
symptoms of sensory deprivation. J Nerv Ment Dis 1959;
129:54–61.
Minion GE, Slovid CM, Boutiette L. Severe alcohol intoxication: a
study of 204 consecutive patients. Clin Toxicol 1989; 27:375–84.
Morley KC, Teesson M, Reid SC et al. Naltrexone versus
acamprosate in the treatment of alcohol dependence: a multicentre,
randomized, double-blind, placebo-controlled trial.
Addiction 2006; 101:1451–62.
Morris HH, Estes ML. Traveler’s amnesia: transient global amnesia
due to triazolam. JAMA 1987; 258:945–6.
Murphy SM, Owen RT, Tyrer PJ. Withdrawal symptoms after six
weeks’ treatment with diazepam. Lancet 1984; 2:1389.
Murphy SM, Owen RT, Tyrer PJ. Comparative assessment of
efficacy and withdrawal symptoms after 6 and 12 weeks’
treatment with diazepam or buspirone. Br J Psychiatry 1989;
154:529–34.
Nielsen J. Delirium tremens in Copenhagen. Acta Psychiatr Scand
1965; 41(suppl. 187):1–92.
Nolte KB, Brass LM, Fletterick CF. Intracranial hemorrhage
associated with cocaine abuse: a prospective autopsy study.
Neurology 1996; 46:1291–6.